Cancer cell associated glycans as targets for immunotherapy.


Therapeutic anti-glycan antibodies for cancer treatment are limited, in spite of the differential glycophenotype of cancer cells and associated biology. We have generated anti-Le glycan antibodies with clinical potential and multifaceted functionality. Increased understanding of all aspects of glycomic research will ensure the continued development of… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.